Literature DB >> 30819347

Diagnosis and Management of Infantile Hemangiomas in the Neonate.

Nicole Harter1, Anthony J Mancini2.   

Abstract

Infantile hemangiomas (IH) are a common benign tumor of infancy, most being uncomplicated and not requiring therapy. Some IH may require treatment; the pediatric provider must be familiar with morphology, distribution, natural history, and associations of IH. Several treatment options are available for IH: current standard of care, oral propranolol. Other therapies include wound care; topical beta-blocker therapy for small, superficial, and uncomplicated IH; treatment of IH residua. In addition to functional compromise and other complications, potential for permanent deformity and eventual psychosocial stigmatization are important when considering the need for treatment of IH in a neonate or infant.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Infantile hemangioma; Neonate; PHACE; Propranolol; Timolol

Mesh:

Substances:

Year:  2019        PMID: 30819347     DOI: 10.1016/j.pcl.2018.12.011

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  8 in total

1.  An ulcerated giant segmental hemangioma resulting in contracture of the left elbow.

Authors:  Alexander K C Leung; Kin Fon Leong; Joseph M Lam
Journal:  Paediatr Child Health       Date:  2020-04-24       Impact factor: 2.253

2.  Excision of an Ulcerated Scrotal Hemangioma in a Four-Month-Old Boy: A Case Report and Review of Literature.

Authors:  Wael M Moneir; Ahmed AlShammari
Journal:  Cureus       Date:  2022-06-11

Review 3.  Imaging of benign cervicofacial vascular anomalies and associated syndromes.

Authors:  Anthony S Larson; Waleed Brinjikji; Katelyn R Anderson; Megha Tollefson; V Michelle Silvera; Julie B Guerin
Journal:  Interv Neuroradiol       Date:  2021-08-16       Impact factor: 1.764

4.  Efficacy of Combined Topical Timolol and Oral Propranolol for Treating Infantile Hemangioma: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Junbo Qiao; Junjie Lin; Dexin Zhang; Junhua Li; Changkuan Chen; Hongye Yu; Xiaodi Li; Bin Fang
Journal:  Front Pharmacol       Date:  2020-10-08       Impact factor: 5.810

5.  Noteworthy effects of a long-pulse Alexandrite laser for treatment of high-risk infantile hemangioma: A case report and literature review.

Authors:  Wen-Ting Su; Ji-Xin Xue; You-Hui Ke
Journal:  World J Clin Cases       Date:  2019-07-26       Impact factor: 1.337

6.  A Clinicopathological Study to Assess the Role of Intralesional Sclerotherapy Following Propranolol Treatment in Infantile Hemangioma.

Authors:  Rakesh Kumar; Preeti Tiwari; Vaibhav Pandey; Amrita Ghosh Kar; Narendra Tiwary; Shiv Prasad Sharma
Journal:  J Cutan Aesthet Surg       Date:  2021 Oct-Dec

7.  MiR-200c-3p increased HDMEC proliferation through the notch signaling pathway.

Authors:  Xianyu Hu; Suwen Bai; Lingyi Li; Pengfei Tian; Sun Wang; Ning Zhang; Bing Shen; Juan Du; Shengxiu Liu
Journal:  Exp Biol Med (Maywood)       Date:  2021-01-20

8.  The effectiveness of oral propranolol for infantile hemangioma on the head and neck region: A case series.

Authors:  Prasetyanugraheni Kreshanti; Nandya Titania Putri; Valencia Jane Martin; Chaula Luthfia Sukasah
Journal:  Int J Surg Case Rep       Date:  2021-06-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.